![]() | This article's tone or style may not reflect the encyclopedic tone used on Wikipedia.(August 2017) |
Marty Makary | |
---|---|
Born | Martin Adel Makary |
Education | |
Medical career | |
Profession | Surgeon |
Field | Abdominal surgery |
Sub-specialties | Islet transplant surgery |
Website | www |
Martin Adel Makary is a British-American surgeon, professor, author and medical commentator. He practices surgical oncology and gastrointestinal laparoscopic surgery at the Johns Hopkins Hospital, is Mark Ravitch Chair in Gastrointestinal Surgery at Johns Hopkins School of Medicine, and teaches public health policy as Professor of Surgery and Public Health at the Johns Hopkins Bloomberg School of Public Health.
Makary is an advocate for disruptive innovation in medicine and physician-led initiatives such as The Surgical Checklist, which he developed at Johns Hopkins, and was later popularized in Atul Gawande's best-selling book The Checklist Manifesto . [1] Makary was named one of the most influential people in healthcare by HealthLeader magazine. [2] In 2018, Makary was elected to the National Academy of Medicine. [3]
During the COVID-19 pandemic, Makary was a prolific pundit, discussing the topics of COVID-19 and mitigation strategies. He was an early advocate for universal masking to control the pandemic and recommends vaccines for adults. [4] However, he has been an outspoken opponent of broad vaccine mandates and some COVID restrictions at schools. [5] [6]
Makary was born in Liverpool, England, and moved to Baltimore as a young child. His family later moved to Danville, Pennsylvania, when his father took a job as a hematologist at the Geisinger Medical Center. Makary holds degrees from Bucknell University, Thomas Jefferson University and Harvard University. He was president of the student body at Harvard, and later served on the alumni board. He completed a Masters of Public Health (M.P.H.) degree, with a concentration in health policy.
Makary completed a surgical residency at Georgetown University [7] in Washington D.C. where he also worked as a writer for The Advisory Board Company. Makary completed sub-specialty surgery training at Johns Hopkins in surgical oncology and gastrointestinal surgery under surgeon John Cameron, before joining Cameron's faculty practice as a partner. [8] In his first few years on the faculty at Johns Hopkins, Makary researched and wrote articles on the prevention of surgical complications. [9] He published on frailty [10] as a medical condition, and on safety and teamwork culture in medicine. Makary is the first author of the original scientific publications describing "The Surgery Checklist". [11] Makary worked with the World Health Organization [12] to develop the official World Health Organization Surgical Checklist. [1] For his contributions to the field of medicine, Makary was named Mark Ravitch Chair in Gastrointestinal Surgery, an endowed chair at the Johns Hopkins University School of Medicine, becoming the youngest endowed chair recipient at the time at the university. Three years later, he was named the Credentials Chair and Director of Quality and Safety for Surgery at Johns Hopkins. [7] In 2020, Makary was named Editor-in-Chief of MedPage Today. He was also appointed chief of the Johns Hopkins Islet Transplant Center, clinical lead for the Johns Hopkins Sibley Innovation Hub, Executive Director of Improving Wisely, a Robert Wood Johnson Foundation project to lower health care costs, is founder of the Johns Hopkins Center For Surgical Outcomes Research and Clinical Trials, and Professor of Surgery and Public Health at the Johns Hopkins Bloomberg School of Public Health. [13]
Makary is a pancreatic surgeon and has pioneered novel surgical procedures. He was awarded the Nobility in Science Award by the National Pancreas Foundation for performing the world's first series of laparoscopic pancreas islet transplant operations. [14] He has traveled with his international team overseas. [15] Makary specializes in advanced laparoscopic surgery and performed the first laparoscopic Whipple surgery at Johns Hopkins and the first laparoscopic Frey's procedure for pancreatitis. [16] [17]
Makary's research led to several partnerships, including a grant from the U.S. Department of Health and Human Services Agency for Healthcare Quality and Research, to study obesity treatment, [18] and a grant from the same agency to implement safety programs at 100 U.S. hospitals, a project he collaborated on with Peter Pronovost and the American College of Surgeons. Makary was also the lead author in the original paper introducing a Hospital Survey of Patient Safety Culture. [19]
He has written for The Wall Street Journal , [20] USA Today , Time, Newsweek , [21] and CNN, [22] and appears on NBC and Fox News. [23]
Makary has also called for the public reporting physician-endorsed quality measures by hospitals. [24] [25] He and Bryan Sexton have encouraged hundreds of hospitals to take the "Culture of Safety Survey" and make their results available to their communities. Makary also advocates for price transparency and has led efforts to ask hospitals to stop suing their low-income patients. [26]
In 2016, Makary and his colleagues exposed loopholes in the Orphan Drug Act accounting for higher drug pricing. His article "The Orphan Drug Act: Restoring the Mission to Rare Diseases", [27] covered by Kaiser Heath News, [28] led Senator Chuck Grassley's office to announce an investigation. [29]
During the COVID-19 pandemic, Makary has been a proponent of treating the COVID-19 pandemic as a true public health threat, [30] masking, [31] vaccines and early vaccination strategies [32] that prioritized maximum coverage against severe disease similar to the UK vaccination strategy, and protection provided by natural immunity. [33] Dr. Makary has also been an outspoken opponent of vaccine mandates, various FDA & CDC policies, and restrictions at colleges and universities. [34]
In February 2020, Makary was vocal that the United States needed to take the threat of COVID-19 seriously and that people should stop all non-essential travel. He warned of disruptions to both the United States healthcare system and to people's daily lives. In addition Makary called for a national lockdown to help slow the spread of the virus and enable the healthcare system to respond and reduce morbidity and mortality. [35] In May 2020, Makary advocated for universal masking in an effort to enable businesses and schools to re-open to minimize economic and educational damage across the United States. [36] In May 2020, it was still debated by many in the scientific community as to whether masks provided much protection against infection, [37] [38] [39] however high-quality masking has proven an effective measure at limiting the spread of COVID-19. [40] [41]
In November 2020, Makary was critical of the pace at which the FDA were approving the mRNA vaccines from Pfizer. [42] Makary had taken issue with the speed at which various US government health organizations had taken to evaluate medications or perform COVID-19 based research. [43] In early February 2021, Makary advocated for prioritizing getting as many vaccinated with single doses vs holding vaccines back for second doses. [44] Single dose vaccination strategies, like done in the United Kingdom, [45] have shown to be effective [46] and conditions upon when to implement single dose vaccination strategies have continued to be researched to assess optimal conditions for single or multiple doses. [47]
Makary stated in a February 2021 op-ed in The Wall Street Journal that "At the current trajectory" in the United States COVID-19 would "be mostly gone by April" 2021, primarily as a result of naturally acquired immunity. [48] The article's estimates of population immunity were criticized for being higher than the best available data supported. [49] On 1 May 2021, the national average 7 day case rate was 105 per 100,000, [50] a rate of community transmission the CDC described as "High Transmission" (the highest of four categories). [51]
Makary considers himself pro-vaccine but has also criticized vaccination mandates for populations other than healthcare workers. [52] Makary recommended a single-dose mRNA vaccine regimen for children 12-17 to minimize the occurrence of myocarditis as a reaction, contrary to the CDC's finding that the risks of infection "far outweigh" those of the two-dose vaccine schedule. [52] [53] In December 2021 he appeared on a podcast to argue against vaccine boosters, referring to himself as an "unboosted male" and saying that the SARS-CoV-2 Omicron variant was "nature's vaccine". [54]
Makary is the author of the New York Times Best Selling book Unaccountable, in which he proposes that common sense, physician-led solutions can fix the healthcare system. [55] [56] The book was turned into the popular TV series, The Resident , which aired on Fox in 2018. [57] Makary is also the author of Mama Maggie a personal story about his distant relative Magda Gobran, a Nobel Peace Prize nominee working in the garbage slums of Cairo. [58] [59] [60] His latest book, The Price We Pay, was released in 2018 and describes how business leaders can lower their health care costs and explores the grass-roots movement to restore medicine to its noble mission. [61] Makary is also the editor of the surgery textbook "General Surgery Review". [62]
Makary is the recipient of numerous research and teaching awards, including the Best Teacher Award for Georgetown Medical School [15] and research awards from the Washington Academy of Surgery and the New England Surgical Society. He has been a visiting professor at over 30 U.S. medical schools and lectures frequently on innovation in health care. [63] In 2018, he was elected to the National Academy of Medicine. [64]
Asplenia refers to the absence of normal spleen function and is associated with some serious infection risks. Hyposplenism is used to describe reduced ('hypo-') splenic functioning, but not as severely affected as with asplenism.
A vaccination policy is a health policy adopted in order to prevent the spread of infectious disease. These policies are generally put into place by state or local governments, but may also be set by private facilities, such as workplaces or schools. Many policies have been developed and implemented since vaccines were first made widely available.
Measles vaccine protects against becoming infected with measles. Nearly all of those who do not develop immunity after a single dose develop it after a second dose. When the rate of vaccination within a population is greater than 92%, outbreaks of measles typically no longer occur; however, they may occur again if the rate of vaccination decreases. The vaccine's effectiveness lasts many years. It is unclear if it becomes less effective over time. The vaccine may also protect against measles if given within a couple of days after exposure to measles.
On December 31, 2019, China announced the discovery of a cluster of pneumonia cases in Wuhan. The first American case was reported on January 20, and President Donald Trump declared the U.S. outbreak a public health emergency on January 31. Restrictions were placed on flights arriving from China, but the initial U.S. response to the pandemic was otherwise slow, in terms of preparing the healthcare system, stopping other travel, and testing. The first known American deaths occurred in February. On March 6, 2020, Trump allocated $8.3 billion to fight the outbreak and declared a national emergency on March 13. The government also purchased large quantities of medical equipment, invoking the Defense Production Act of 1950 to assist. By mid-April, disaster declarations were made by all states and territories as they all had increasing cases. A second wave of infections began in June, following relaxed restrictions in several states, leading to daily cases surpassing 60,000. By mid-October, a third surge of cases began; there were over 200,000 new daily cases during parts of December 2020 and January 2021.
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).
COVID-19 infection in pregnancy is associated with several pregnancy complications. However, pregnancy does not appear to increase the susceptibility of becoming infected by COVID-19. Recommendations for the prevention of COVID-19 include the same measures as non-pregnant people.
The COVID-19 pandemic has impacted hospitals around the world. Many hospitals have scaled back or postponed non-emergency care. This has medical consequences for the people served by the hospitals, and it has financial consequences for the hospitals. Health and social systems across the globe are struggling to cope. The situation is especially challenging in humanitarian, fragile and low-income country contexts, where health and social systems are already weak. Health facilities in many places are closing or limiting services. Services to provide sexual and reproductive health care risk being sidelined, which will lead to higher maternal mortality and morbidity. The pandemic also resulted in the imposition of COVID-19 vaccine mandates in places such as California and New York for all public workers, including hospital staff.
The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant and 61% against the Delta variant.
Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.
CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in humans to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) that encodes a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial guidance recommended a two-dose regimen, given 21 days apart; this interval was subsequently extended to up to 42 days in the United States, and up to four months in Canada.
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.
Israel's COVID-19 vaccination programme, officially named "Give a Shoulder", began on 19 December 2020, and has been praised for its speed, having given twenty percent of the Israeli population the first dose of the vaccines' two dose regimen in the span of three weeks.
As of 3 January 2024, 13.53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million vaccines were then being administered daily, only 22.3 percent of people in low-income countries had received at least a first vaccine by September 2022, according to official reports from national health agencies, which are collated by Our World in Data.
Martin Kulldorff is a Swedish biostatistician. He was a professor of medicine at Harvard Medical School from 2003 until his dismissal in 2024. He is a member of the US Food and Drug Administration's Drug Safety and Risk Management Advisory Committee and a former member of the Vaccine Safety Subgroup of the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention.
The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and was ranked number one in the European Union in terms of its percentage of adult population fully vaccinated, and was also ranked number one in the EU for the number of booster vaccines administered.
Peter Andrew McCullough is an American cardiologist. He was vice chief of internal medicine at Baylor University Medical Center and a professor at Texas A&M University. From the beginnings of the COVID-19 pandemic, McCullough has promoted misinformation about COVID-19, its treatments, and mRNA vaccines.
Fractional dose vaccination is a strategy to reduce the dose of a vaccine to achieve a vaccination policy goal that is more difficult to achieve with conventional vaccination approaches, including deploying a vaccine faster in a pandemic, reaching more individuals in the setting of limited healthcare budgets, or minimizing side effects due to the vaccine.
In many countries a variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion, and law. These have included exaggerated claims about side effects, misrepresentations about how the immune system works and when and how COVID-19 vaccines are made, a story about COVID-19 being spread by 5G, and other false or distorted information. This misinformation, some created by anti-vaccination activists, has proliferated and may have made many people averse to vaccination. This has led to governments and private organizations around the world introducing measures to incentivize or coerce vaccination, such as lotteries, mandates, and free entry to events, which has in turn led to further misinformation about the legality and effect of these measures themselves. {{TOC limit|4}
Vaccine equity means ensuring that everyone in the world has equal access to vaccines. The importance of vaccine equity has been emphasized by researchers and public health experts during the COVID-19 pandemic but is relevant to other illnesses and vaccines as well. Historically, world-wide immunization campaigns have led to the eradication of smallpox and significantly reduced polio, measles, tuberculosis, diphtheria, whooping cough, and tetanus.
{{cite journal}}
: CS1 maint: numeric names: authors list (link){{cite book}}
: CS1 maint: location missing publisher (link){{cite book}}
: CS1 maint: location missing publisher (link)